Market volatility in 2026 has reminded investors that earned income alone is fragile. When tariff fears rattle equities and economic uncertainty clouds the outlook, dividend investors sleep better. Passive income from dividend stocks requires only that you own the right companies.
A well-constructed dividend portfolio generates cash flow every quarter, whether markets rise or fall. Unlike rental real estate, dividend stocks offer instant liquidity. Unlike savings accounts, the best dividend payers raise distributions year after year, compounding income over time.
We screened our 24/7 Wall St. dividend equity research database and found five companies that, combined, can generate over $1,700 annually in passive income on a $10,000 investment in each stock.
Johnson & Johnson
- Yield: 2.29%
- Shares for $10,000: 42.70
- Annual Passive Income: $229
Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) operates across Innovative Medicine and MedTech. Innovative Medicine posted $15.43 billion in Q1 2026 revenue, up 11.2% year over year, driven by immunology and oncology franchises. MedTech added $8.64 billion, up 7.7%. Full-year 2026 revenue guidance stands at $100 billion to $101 billion.
Johnson & Johnson has raised its payout for 64 consecutive years, earning Dividend King status. The most recent increase, declared April 14, 2026, lifted the quarterly payment to $1.34 per share, annualizing to $5.36.
Coca-Cola
- Yield: 2.80%
- Shares for $10,000: 132.03
- Annual Passive Income: $280
Coca-Cola (NYSE:KO) is the world’s largest nonalcoholic beverage company, headquartered in Atlanta, Georgia, with interests spanning concentrate manufacturing, retailing, and marketing across more than 200 countries. Its brand portfolio generates pricing power that underpins a dividend raised for 63 consecutive years. The company distributed $8.8 billion in dividends in 2025 and expects free cash flow of approximately $12.2 billion in 2026.
The most recent quarterly dividend came in at $0.53 per share, up from the $0.51 rate throughout 2025, annualizing to $2.12. Full-year 2026 guidance calls for organic revenue growth of 4% to 5% and comparable EPS growth of 7% to 8% against a $3 base. Institutions hold 66.7% of shares, and 24 analysts cover the stock with a consensus target of $83.67.
Procter & Gamble
- Yield: 2.96%
- Shares for $10,000: 68.06
- Annual Passive Income: $296
Procter & Gamble (NYSE:PG) is one of the world’s largest consumer goods companies, with brands including Tide, Pampers, Gillette, and Oral-B spanning beauty, grooming, health care, and home care. Fiscal Q2 2026 revenue came in at $22.21 billion, up 1.5% year over year. The company plans to distribute approximately $10 billion in dividends for fiscal 2026, reflecting its commitment to returning cash to shareholders.
Procter & Gamble raised its quarterly dividend to $1.088 per share, with the ex-dividend date on April 24, 2026, annualizing to $4.35. The company has raised its dividend for decades, qualifying as a Dividend King. Institutional investors hold 70.4% of shares, and the analyst consensus price target sits at $164.18, implying upside from the current price of $146.93.
AbbVie
- Yield: 3.32%
- Shares for $10,000: 47.99
- Annual Passive Income: $332
AbbVie (NYSE:ABBV) is a biopharmaceutical company spun off from Abbott Laboratories in 2013, generating revenue through a diversified immunology and oncology portfolio. Skyrizi and Rinvoq have become the post-Humira growth engines, with Skyrizi revenue rising 32.5% in Q4 2025 and Rinvoq growing 29.5%. Q4 2025 revenue reached $16.62 billion, up 10% year over year. Full-year 2026 adjusted EPS guidance is $14.37 to $14.57.
The quarterly dividend stands at $1.73 per share, following a 5.5% increase in Q3 2025, annualizing to $6.92. The ex-dividend date of April 15, 2026 has passed, with the next payment due May 15, 2026. Institutional investors hold 76.5% of shares, and 22 analysts cover AbbVie with a consensus target of $249, well above the current price of $208.38.
Altria Group
- Yield: 6.61%
- Shares for $10,000: 155.84
- Annual Passive Income: $661
Altria Group (NYSE:MO) is the dominant force in U.S. tobacco, with Marlboro anchoring its Smokeable Products segment. Headquartered in Richmond, Virginia, the company generates substantial free cash flow from a mature, price-inelastic consumer base, channeling it directly to shareholders. The current quarterly dividend is $1.06 per share, annualizing to $4.24, and the company has delivered 60 dividend increases over 56 years. The most recent increase of 3.9% was declared in August 2025.
Altria’s yield is structurally elevated because tobacco’s secular volume decline compresses the stock’s valuation multiple. That same dynamic makes the dividend attractive for income investors focused on cash generation.
The company is executing a $2 billion share repurchase program through December 2026. Institutional investors hold 63.7% of shares, and 2026 adjusted EPS guidance of $5.56 to $5.72 supports continued dividend coverage.
The bottom line
Combined, these five positions generate $1,797 in annual passive income on a $50,000 investment, a blended yield of 3.60%.
Altria contributes $661, AbbVie adds $332, Procter & Gamble delivers $296, Coca-Cola rounds in at $280, and Johnson & Johnson contributes $229. These five companies have collectively raised their payouts across more than 200 combined years of consecutive increases, making passive income investing worth building around.
Leave a comment